Especially in estrogen receptor (ER)- progesterone receptor (PR)- HER2- triple-negative breast cancer (TNBC), it promotes migration and invasion in vitro and growth and metastasis in vivo. This evidence concerns the gene ESR1 and triple-negative breast carcinoma.